Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 3/2008

01-06-2008 | Images in Infection

Tuberculous Spondylitis (Pott’s Disease)

Authors: A. P. Nigg, H. Schulze-Koops, S. Wirth, M. Weiss, J. R. Bogner

Published in: Infection | Issue 3/2008

Login to get access
Metadata
Title
Tuberculous Spondylitis (Pott’s Disease)
Authors
A. P. Nigg
H. Schulze-Koops
S. Wirth
M. Weiss
J. R. Bogner
Publication date
01-06-2008
Publisher
Urban & Vogel
Published in
Infection / Issue 3/2008
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-008-2003-3

Other articles of this Issue 3/2008

Infection 3/2008 Go to the issue

Case Report

Pulmonary Histoplasmosis in Three Austrian Travelers After a Journey to Mexico

Case Report

Cryoglobulinemia-Related Vasculitis During Effective Anti-HCV Treatment with PEG-Interferon alfa-2b

Case Report

Burkholderia cepacia as a Cause of Ecthyma Gangrenosum-like Lesion

Clinical and Epidemiological Study

Diabetes as a Risk Factor for Herpes Zoster Infection: Results of a Population-Based Study in Israel

Editorial

Treatment of Infectious Diseases – Taking Unexpected Drug Effects into Consideration

Clinical and Epidemiological Study

Monocyte Phagocytosis of Viable Staphylococcus aureus is Impaired by Barbiturates, but not by Propofol

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits